| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-08 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-08 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |